KSHV ORF65 peptide

  • Description

  • Application Data

Description

Peptide from open reading frame 65 (ORF65) of Kaposi’s sarcoma-associated herpesvirus (KSHV)

See full description

Application Data

Catalogue number crb1200467
Antibody KSHV ORF65 peptide
Antigen Peptide KSHV ORF65 peptide
Protein ID GenBank: ABD28922.1. UniProtKB - Q2HR63
Aliases Kaposi sarcoma-associated herpesvirus (KSHV) ORF65, Human gammaherpesvirus 8 ORF65, HHV-8 ORF65, Small capsomere-interacting protein
Cross-Reactivity KSHV
Specificity Protein
Citations

Lin, S., Sun, R., Heston, L., Gradoville, L., Shedd, D., Haglund, K., Rigsby, M., Miller, G. (1997). Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol, 71(4), 3069-76. PMID: 9060668

References

Lin, S., Sun, R., Heston, L., Gradoville, L., Shedd, D., Haglund, K., Rigsby, M., Miller, G. (1997). Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol, 71(4), 3069-76. PMID: 9060668

Data Sheet Material Safety Data Sheet (MSDS)

Antigenic peptide corresponding to region of lytic-phase viral capsid antigen (vp19)/small viral capsid antigen (sVCA), encoded by open reading frame 65 (ORF65) from Kaposi’s sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8). HHV8/KSHV belongs to the gamma-2 or rhadinovirus sub-lineage of the Gammaherpesvirinae subfamily and is strongly associated with AIDS related malignancies. These malignancies include; Kaposi’s sarcoma (KS) – a rare cancer that causes skin and mouth lesions; primary effusion lymphoma (PEL) – a B-cell lymphoma; and Castleman’s disease – characterised by over proliferation of the lymph node.

KSHV ORF65 peptide

Cat No.Pack SizePriceQty.
50ug£85.00
Bulk Quote